Hong Kong’s Hang Seng index gained 2.17%, or 448.23 points, to close at 21,056.93. Meanwhile, Chinese stocks rose 1.18% on the Shanghai Composite, which ended up 35.90 points at 3,087.84. Trading volumes were heavy on both exchanges.

In recent trading, May copper futures were up about 8 cents, over 2%, at $3.36 a pound on the Comex division of the New York Mercantile Exchange. The commodity reached as high as $3.48, its strongest point since January, in electronic trading over the weekend after the 8.8 magnitude quake struck Chile.

China’s announced an increase in bank reserve requirements by 0.5% for the second time in five weeks in order to limit lending to consumers and businesses. The country is hoping that the move will help slow down the country’s rapid economic growth.

The country’s Bureau of Statistics noted on Thursday that annual inflation had more than doubled in January versus the prior month, to 4.3%. Meanwhile, the average housing price rose 9.5% last month from a year earlier, which is the fastest rate in 19 months.

Luckily for the country, the rising asset prices have not yet impacted consumer prices, which had caused unrest in the past when eroding workers’ spending power. Obviously, this is a bad situation as it can lead to class division and other socioeconomic problems.

The certificate authorizes the Company to provide valves for conventional islands of nuclear power plants commissioned by CNPEC, as defined by the Company’s Special Equipment Manufacturing License issued by China’s State Quality Supervision & Inspection Bureau. In addition, the Company is also qualified to supply valves for Balance of Plant (BOP), the supporting system in a nuclear power plant. Only a few out of several thousands of valve manufacturers have obtained this certification from CNPEC. In order to qualify as a supplier, manufacturers must meet a range of predefined standards, such as having the ability to produce valves for power plants with a generation capacity of at least 300MW.

The Company estimates that approximately 45% of all valves in a typical nuclear power plant are used in the conventional island, while 11% are used in the BOP.

State-owned CNPEC, China’s largest company engaged in nuclear power research, development and operation, undertakes and has completed the most nuclear power engineering projects in China. Additionally, CNPEC has generated more than 300 nuclear power related industry standards and has a prominent role in the development and implementation of a plan for the nuclear power industry under China’s Eleventh Five-Year Plan.

“This certificate is an indication of confidence in our ability to deliver high-quality valves for demanding applications in the emerging nuclear power industry,” said Mr. Siping Fang, Chairman and Chief Executive Officer of China Valves. “China is aiming to become self-sufficient in nuclear power development, and is therefore increasingly relying on high-quality domestic suppliers. China Valves hopes to capitalize on this growing demand by actively developing our product offerings and improving quality.”

China Valves is already certified to supply valves used in conventional islands for China’s second largest nuclear power development company, Guangdong Nuclear Power Group (”GNPG”). It has yet to obtain the license to manufacture valves used in the core island of nuclear power plants.

About China Valves Technology, Inc.

China Valves Technology, Inc. through its subsidiaries, Zhengzhou Zhengdie Valve Co, Ltd., Henan Kaifeng High Pressure Valve Co., Ltd., Tai Zhou Tai De Valve Co., Ltd. and Yangzhou Rock Valve Lock Technology Co., Ltd., is engaged in development, manufacture and sale of high-quality metal valves for the electricity, petroleum, chemical, water, gas and metallurgy industries. The Company has one of the best known brand names in China’s valve industry, and its history can be traced back to 1959 when it was formed as a state-owned enterprise. The Company develops valve products by extensive research and development and owns a number of patents. It enjoys significant domestic market shares and exports to Asia and Europe. For more information, visit http://www.cvalve.com

Safe Harbor Statements

Any statements set forth above that are not historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors include, but are not limited to, the Company’s ability to develop and market new products, expectations regarding the financial performance of Yangzhou Rock, the ability to acquire other companies, changes from anticipated levels of sales, changes in national or regional economic and competitive conditions, changes in relationships with customers, changes in principal product profits and other factors detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to update or revise to the public any forward-looking statements, whether as a result of new information, future events or otherwise. This press release was developed by China Valves, and is intended solely for informational purposes and is not to be construed as an offer or solicitation of an offer to buy or sell the Company’s stock. This press release is based upon information available to the public, as well as other information from sources which management believes to be reliable, but it is not guaranteed by China Valves to be accurate, nor does China Valves purport it to be complete. Opinions expressed herein are those of management as of the date of publication and are subject to change without notice.

While the move to limit growth is ultimately good for the economy, according to many economists, the slowdown will surely constrict the country’s investments and slow down the rapid growth in household wealth that came on the heels of the boom.

Currently, these concerns are merely rumors and not confirmed fact. But ultimately, rumors are all it takes to move the markets. Hong Kong’s Hang Seng index fell 1.31% or 283.75 points to 21,394.23, while China’s Shanghai index fell 1.04% to 3,213.17.

Major Chinese banks also moved lower during the session. Bank of China dropped 2.93%, China Construction Bank fell 2.65%, and Industrial and Commercial Bank of China dropped 1.98%. Meanwhile, other financials were also lower, forcing the average down 1.42%.

Notably, there are several actions that have already been taken that are not simply rumors. China’s central bank has ordered at least two banks to lift their reserve ratios by 0.5%, while also clamping down on excess liquidity via raising short-term debt yields over the past two weeks.

Combined, the speculation and confirmed actions have led to a global drop in equity prices. Latin American stocks in particular were hit as China represents a major export market for raw materials and commodities from countries like Brazil.

The Company has begun production on four new proprietary high speed manufacturing lines. The new lines increase Lihua’s copper wire capacity from 1,000 metric tons per month to 1,500 metric tons per month and CCA wire capacity from 500 metric tons per month to 600 metric tons per month.

To supplement and capitalize on its well-established CCA business and proprietary cleaning technologies, at the end of the first quarter of 2009, Lihua began utilizing refined, or recycled, copper to manufacture and sell low content oxygen copper cable and copper magnet wire to its existing customer base. Lihua’s copper recycling facility operates two horizontal smelters for a current production capacity of 25,000 tons per annum.

“As CCA and recycled copper magnet wire are increasingly accepted as alternatives to pure copper wire magnet wire, we are leveraging our fine wire expertise to develop new products and processes while aggressively growing our production capacity to meet surging domestic demand,” said Jianhua Zhu, Chairman and Chief Executive Officer of Lihua. “Our highly scalable production facilities and competitive supply chain advantages allow us to steadily add capacity while maintaining healthy margins. We believe that our emphasis on technological innovation and production efficiency has contributed significantly to our leading industry position in China and will enable us to capture a growing share of an enormous market opportunity.”

Market Demand

Lihua’s proprietary copper-cleaning technology, which produces 99.96% copper purity, puts the Company in a leadership position within the world’s largest addressable market for copper consumption. China ranks as the largest copper consuming country in the world with a market share of approximately 22% of global demand. Experts have indicated that China’s four trillion RMB stimulus package should assist in sustaining the rate of copper demand through ongoing and accelerating housing and infrastructure investments.

About Lihua International, Inc.

Lihua International, through its two wholly-owned subsidiaries, Lihua Electron and Lihua Copper, is a leading value-added manufacturer of copper replacement products for China’s rapidly growing magnet and fine wire market. Lihua is one of the first vertically integrated companies in China to develop, design, manufacture, market and distribute lower cost, high quality, alternatives to pure copper magnet wire. Lihua’s products include copper-clad aluminum wire (”CCA”) and recycled scrap copper wire and are sold in China either directly to manufacturers or through distributors in the wire and cable industries and manufacturers in the consumer electronics, white goods, automotive, utility, telecommunications and specialty cable industries. Lihua’s corporate and manufacturing headquarters are located in the heart of China’s copper industry in Danyang, Jiangsu Province. http://www.lihuaintl.com

As of Monday, October 5, 2009, Lihua was ranked the No. 1 performing IPO to date in 2009 with a 152% increase in stock price since the beginning of trading on September 4th.

To be added to the Company’s email distribution for future news releases, please send your request to lihua@tpg-ir.com.

The net proceeds from the offering will be used to repay the Company’s $50 million Tranche A Zero Coupon Guaranteed Senior Unsecured Convertible Notes for a purchase price of $47.5 million, as specified in a non-binding term sheet signed between the Company and Citadel Equity Fund Ltd. Pending such repayments the Company will use the remaining net proceeds from the offering for working capital and general corporate purposes.

About China Security & Surveillance Technology, Inc.

Based in Shenzhen, China, CSST manufactures, distributes, installs and services surveillance and safety products and systems as well as develops surveillance and safety related software in China. Its customers are mainly comprised of commercial and government entities and non-profit organizations. CSST has built a diversified customer base through its extensive sales and service network that includes over 150 branch offices and distribution points throughout China. To learn more about the Company visit http://www.csst.com .

For further details, please contact your institutional sales representative.

About China Aoxing Pharmaceutical Company, Inc.

China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) is a pharmaceutical company located in China specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. It has a strategic alliance with American Oriental Bioengineering, Inc. (NYSE: AOB) to develop and market various narcotic drugs in China. Headquartered in Shijiazhuang City, the pharmaceutical capital of China, outside of Beijing, China Aoxing has China’s largest and the most advanced manufacturing facility for highly regulated narcotic medicines, addressing a very under-served and fast-growing market in China. Its facility is one of the few GMP facilities licensed for narcotics medicines. The Company is working closely with the Chinese government and SFDA to assure the strictly regulated availability to medical professionals of its narcotic drugs and pain medicines throughout China.

Statements made in this press release are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The economic, competitive, governmental, technological and other risk factors identified in the Company’s filings with the Securities and Exchange Commission, including the Form 10-KSB for the year ended June 30, 2008, may cause actual results or events to differ materially from those described in the forward looking statements in this press release. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

The net proceeds from the offering will be used to repay the Company’s $50 million Tranche A Zero Coupon Guaranteed Senior Unsecured Convertible Notes for a purchase price of $47.5 million, as specified in a non-binding term sheet signed between the Company and Citadel Equity Fund Ltd. Pending such repayments the Company will use the net proceeds from the offering for working capital and general corporate purposes.

Mr. Guoshen Tu, Chief Executive Officer of CSST, commented, “We are very pleased by the strong interest to our offering and to be able to sign the term sheet with Citadel to retire the Tranche A Notes. We believe the combination of these two transactions will further strengthen our balance sheet, create additional cost savings, improve future cash flows, and enhance our capital structure. These ongoing efforts should augment our financial flexibility and help us support our strategic expansion and long term growth.”

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any jurisdiction. The shares of common stock may only be offered by means of a prospectus. Copies of the final prospectus supplement and accompanying base prospectus can be obtained from Brean Murray, Carret & Co., LLC (570 Lexington Avenue, 11th Floor, New York, NY 10022, fax +1-212-702- 6548), or from China Security & Surveillance Technology, Inc. (13/F, Shenzhen Special Zone Press Tower, Shennan Road, Futian District, Shenzhen, People’s Republic of China, 518034).

Existing Notes Details

On September 2, 2009, the Company restructured its two 1% Guaranteed Senior Unsecured Convertible Notes due 2012 into two new tranches of notes: the Tranche A Zero Coupon Guaranteed Senior Unsecured Convertible Notes (the “Tranche A Notes”) and the Tranche B Zero Coupon Guaranteed Senior Unsecured Notes (the “Tranche B Notes”).

The Tranche A Notes have a principal amount of $50 million, zero coupon interest, and mature on September 2, 2012. The Company will repay the principal amount in six consecutive semi-annual installments, starting March 2, 2010, with 25%, 25% and 50% of the principal amount to be repaid in the first, second and third year, respectively. The conversion price will be $10.00 per share initially, subject to customary conversion price adjustments, anti- dilution protections and a one-time price reset on March 2, 2011 (the ‘Reset Date’) based on the volume weighted average price of the Company’s shares during the 45 trading days immediately preceding the Reset Date, provided that the conversion price shall be adjusted to no lower than $6.00 per share.

The Tranche B Notes, which are not convertible, have a principal amount of $84 million, zero coupon interest, and mature on September 2, 2012. The Company will repay the principal amount in six consecutive semi-annual installments, starting March 2, 2010, with 46%, 46% and 8% of the principal amount to be repaid in the first, second and third year, respectively.

The Company is entitled to redeem the two tranches of notes at any time with no premium or penalty at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus default interest, if any.

About China Security & Surveillance Technology, Inc.

Based in Shenzhen, China, CSST manufactures, distributes, installs and services surveillance and safety products and systems as well as develops surveillance and safety related software in China. Its customers are mainly comprised of commercial and government entities and non-profit organizations. CSST has built a diversified customer base through its extensive sales and service network that includes over 150 branch offices and distribution points throughout China. To learn more about the Company visit http://www.csst.com .

China Pharma expects to begin trading on NYSE Amex on Wednesday, September 30, 2009. In connection with its listing on NYSE Amex, the Company’s ticker symbol will change to “CPHI” from “CPHI.OB.”

Ms. Zhilin Li, CEO and President of China Pharma, commented, “It is a major milestone to move to NYSE Amex, and we are proud of our fulfillment of this target. We believe that NYSE Amex provides excellent exposure for companies from emerging markets, such as ours. This step underscores our commitment to generating long-term value for our shareholders.”

About China Pharma Holdings, Inc.

China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company’s cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit http://www.chinapharmaholdings.com .

The Summit marks the first UN visit for the Presidents of China and the United States. This participation clearly underlines the degree of commitment to change at the highest levels of world government. “Failure to reach broad agreement in Copenhagen would be morally inexcusable, economically short-sighted and politically unwise,” the Secretary-General said in his opening address. “Now is the moment to act in common cause.”

It is against this backdrop of political will and resultant extraordinary potential for increased industry momentum that will directly affect the future positive growth of the wind power sector in China, that GC China Turbine Corp. is pleased to announce the final framework for a definitive agreement (the “Agreement”) with Wuhan Guoce Nordic New Energy Co. Ltd., a People’s Republic of China Company (”GC Nordic”), and all related parties have met, thus paving the way for the execution of the share exchange agreement by the end of the month.

All parties have agreed to the terms and conditions of a formal, definitive agreement, which will see the Company consummate a voluntary share exchange with the parent company of GC Nordic by acquiring all of the issued and outstanding capital stock of the parent company of GC Nordic in exchange for the issuance of shares of common stock of the Company, which will represent a fifty four percent (54%) ownership interest in the Company post-Closing (the “Exchange”). As a result, upon consummation of the Exchange, the Company shall indirectly own all of the outstanding capital stock of GC Nordic. Furthermore, the previously announced $10,000,000 loan made to the Company will be converted into shares of the Company’s common stock.

It is anticipated that an announcement of the formal closing providing further details of the agreement will be made shortly.

Wuhan Guoce Nordic New Energy Co. Ltd. (GC Nordic) is a wind turbine manufacturing venture and affiliate of the highly regarded and successful multi-division Wuhan Guoce Group of Companies. The organization is a well established manufacturer of hydraulic and electronic systems offering direct access to a national client base representing a large industrial market share with extensive vertical penetration opportunities across the People’s Republic of China (”PRC”). The company holds a license to manufacture a robust and innovative wind turbine system originally developed in Europe.

Further details regarding the Company and complete details of the Exchange with GC Nordic are filed as part of the Company’s continuous public disclosure as a reporting issuer under the Securities Exchange Act of 1934 filed with the Securities and Exchange Commission’s (”SEC”) EDGAR database.